Aliases & Classifications for Drug-Induced Hepatitis

About this section

Drug-Induced Hepatitis, Aliases & Descriptions:

Name: Drug-Induced Hepatitis 30 9
Hepatitis, Chronic, Drug-Induced 60
 
Drug-Induced Chronic Hepatitis 9
Hepatitis, Drug-Induced 60


External Ids:

Disease Ontology9 DOID:2044
SNOMED-CT55 235889003
MeSH33 D056487

Summaries for Drug-Induced Hepatitis

About this section


MalaCards based summary: Drug-Induced Hepatitis, also known as hepatitis, chronic, drug-induced, is related to hepatitis and tuberculosis. An important gene associated with Drug-Induced Hepatitis is UGT1A3 (UDP glucuronosyltransferase 1 family, polypeptide A3), and among its related pathways are Etoposide Pathway, Pharmacokinetics/Pharmacodynamics and Carbamazepine Pathway, Pharmacokinetics. The compounds thiopurine and flunitrazepam have been mentioned in the context of this disorder. Affiliated tissues include liver, testes and t cells, and related mouse phenotype homeostasis/metabolism.

Related Diseases for Drug-Induced Hepatitis

About this section

Diseases related to Drug-Induced Hepatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 108)
idRelated DiseaseScoreTop Affiliating Genes
1hepatitis31.2CYP2E1, GPT, ALB, GLUD1, SLC17A5
2tuberculosis30.8CYP2E1, TNF, NAT2, ALB
3autoimmune hepatitis29.8UGT1A1, CYP2D6, CYP2C9, GPT, GSTT1, SLC17A5
4hepatitis b29.7GPT, NAT2, ALB, GSTT1, SLC17A5
5crigler-najjar syndrome, type i10.5UGT1A1
6pulmonary tuberculosis10.4
7gilbert syndrome10.4UGT1A1, NAT2
8brain cancer10.4GSTM1, GSTT1
9asbestosis10.4GSTM1, GSTT1
10neuroleptic malignant syndrome10.4CYP2D6
11fatty liver disease10.4CYP2E1, SLC17A5
12fascioliasis10.4SORD, SLC17A5
13mismatch repair cancer syndrome10.3GSTM1, GSTT1
14bladder cancer, somatic10.3NAT2, NAT1, GSTM1
15choledocholithiasis10.3GPT, SLC17A5
16pancreatitis, hereditary10.3UGT1A1, CYP2E1, GSTT1
17alcoholic hepatitis10.3CYP2E1, TNF
18open-angle glaucoma10.3GSTT1, GSTM1
19pyridoxine deficiency10.3GPT, SLC17A5
20hepatitis a10.2
21aplastic anemia10.2CYP2D6, GSTM1, GSTT1
22diabetic cataract10.2SORD, CAT
23nasopharyngeal carcinoma10.2CYP2E1, NAT2, GSTM1, GSTT1
24hepatorenal syndrome10.2ALB
25endometriosis10.2NAT2, GSTM1, GSTT1
26obstructive jaundice10.2GPT, SLC17A5
27acute lymphoblastic leukemia, childhood10.2CYP2E1, NAT1, GSTM1, GSTT1
28acute myeloid leukemia, adult10.2GSTM1, GSTT1
29transitional cell carcinoma10.2NAT2, NAT1, GSTM1, GSTT1
30gastric adenocarcinoma10.2NAT2, NAT1, GSTM1, GSTT1
31basal cell carcinoma10.2GSTT1, GSTM1, CYP2D6
32senile cataract10.2CAT, GSTM1, GSTT1
33hellp syndrome10.2SLC17A5, GPT
34alcohol abuse10.2CYP2E1, GPT, SLC17A5
35cholelithiasis10.2GPT, UGT1A1
36scrub typhus10.2SLC17A5, GPT
37squamous cell carcinoma, head and neck10.2CYP2D6, NAT2, GSTM1, GSTT1
38nicotine dependence, protection against10.1CYP2E1, NAT2, NAT1, GSTM1, GSTT1
39periodontal disease10.1TNF, NAT2, SLC17A5
40lymphoma, non-hodgkin10.1CYP2E1, NAT2, NAT1, GSTM1, GSTT1
41kernicterus10.1UGT1A1, ALB
42oral cancer10.1CYP2E1, CAT, GSTM1, GSTT1
43bilirubin metabolic disorder10.1UGT1A3, UGT1A1, ALB
44schizophrenia10.1GLUD1, CYP2C9, CYP2D6, CYP2C19
45multiple myeloma10.1
46hyperinsulinism10.1
47dystonia10.1
48melanoma10.1
49meningitis10.1
50myeloma10.1

Graphical network of the top 20 diseases related to Drug-Induced Hepatitis:



Diseases related to drug-induced hepatitis

Symptoms for Drug-Induced Hepatitis

About this section

Drugs & Therapeutics for Drug-Induced Hepatitis

About this section

Drug clinical trials:

Search ClinicalTrials for Drug-Induced Hepatitis

Search NIH Clinical Center for Drug-Induced Hepatitis

Genetic Tests for Drug-Induced Hepatitis

About this section

Anatomical Context for Drug-Induced Hepatitis

About this section

MalaCards organs/tissues related to Drug-Induced Hepatitis:

31
Liver, Testes, T cells

LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Drug-Induced Hepatitis:
id TissueAnatomical CompartmentCell Relevance
1 LiverLiver LobuleHepatocytes Affected by disease

Animal Models for Drug-Induced Hepatitis or affiliated genes

About this section

MGI Mouse Phenotypes related to Drug-Induced Hepatitis:

35
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053765.7SLC17A5, TNF, SORD, NAT2, NAT1, GHR

Publications for Drug-Induced Hepatitis

About this section

Articles related to Drug-Induced Hepatitis:

(show top 50)    (show all 91)
idTitleAuthorsYear
1
Epstein-Barr Virus Infection Mimicking Drug-Induced Hepatitis in a Critically ill Patient During Antituberculosis Therapy. (25368656)
2014
2
Comment on "No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance" by Ubaldo Visco-Comandini et al. [Dig. Liver Dis. 2014;46:348-52]. (24815081)
2014
3
Comments on 'Risk factors for drug induced hepatitis with first-line antituberculosis drugs in hospitalized patients of pulmonary tuberculosis'. (24823542)
2014
4
A rare coexistence: drug induced hepatitis and meningitis in association with Ibuprofen. (23671551)
2013
5
Cytochrome P450 2E1 gene polymorphisms/haplotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohort. (23460870)
2013
6
Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature. (24109195)
2013
7
Anti-tuberculosis drug-induced hepatitis in renal transplant patient with pulmonary and extra pulmonary tuberculosis. (23960791)
2012
8
A Case of Drug-Induced Hepatitis due to Bortezomib in Multiple Myeloma. (22916049)
2012
9
TNF-I+ genetic polymorphism -308G/A and antituberculosis drug-induced hepatitis. (22151084)
2012
10
Drug-induced hepatitis following use of octreotide for long-term treatment of congenital hyperinsulinism. (22850563)
2012
11
Relationship between the polymorphisms of UGT1A6 genes and anti-tuberculosis drug induced hepatic-injury]. (21586239)
2011
12
Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases. (19535968)
2010
13
NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis. (20392357)
2010
14
Drug-induced hepatitis and lupus during infliximab treatment for psoriasis: case report and literature review. (20338127)
2010
15
The effect of GST M1 and GST T1 gene mutations on anti-tuberculous drug induced hepatic injury]. (19576039)
2009
16
Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis. (19891553)
2009
17
Acute drug-induced hepatitis caused by albendazole. (18955802)
2008
18
Acute drug induced hepatitis due to erlotinib. (17228132)
2007
19
Drug induced hepatitis with anti-tubercular chemotherapy: challenges and difficulties in treatment. (18604033)
2007
20
Drug-induced hepatitis in an acromegalic patient during combined treatment with pegvisomant and octreotide long-acting repeatable attributed to the use of pegvisomant. (16728538)
2006
21
Drug-induced hepatitis in a patient with malignant melanoma treated with interferon alfa 2b adjuvantly who had been administered gemfibrozil in therapy. (16645237)
2006
22
Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in pathogenesis of idiosyncratic drug-induced hepatitis. (16467335)
2006
23
A case of acute drug-induced hepatitis. (16607204)
2006
24
Drug-induced hepatitis with saquinavir/ritonavir + rifampin. (15828118)
2005
25
Drug-induced hepatitis, drug-induced autoimmunity or classical autoimmune hepatitis: how can we differentiate? (15492907)
2004
26
Secular increase in the incidence rate of drug-induced hepatitis due to anti-tuberculosis chemotherapy including isoniazid and rifampicin]. (12739393)
2003
27
Antituberculosis drug-induced hepatitis: risk factors, prevention and management. (15332488)
2003
28
Drug-induced hepatitis with autoimmune features during minocycline therapy. (12583618)
2003
29
Clinical pharmacology consultations: consultation requests may be misleading -- an organized approach to drug-induced hepatitis. (12879142)
2003
30
Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. (12668988)
2003
31
Drug-induced hepatitis with hepatic granuloma due to saridon. (12522541)
2002
32
Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. (11915035)
2002
33
Comment: history of drug-induced hepatitis and risk of amoxicillin/clavulanate-induced hepatotoxicity. (11793648)
2001
34
Effects of the enterosorbent SUMS-1 on isoniazid pharmacokinetics and lipid peroxidation in patients with pulmonary tuberculosis and drug-induced hepatic lesions]. (11508231)
2001
35
Drug-induced hepatitis]. (10647202)
1999
36
Nonsteroidal antiinflammatory drug-induced hepatitis. (9533071)
1998
37
Diagnostic value of T cell reactivity in drug induced hepatitis. (9917196)
1998
38
Immunoallergic drug-induced hepatitis: lessons from halothane. (9138123)
1997
39
Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis. (9138125)
1997
40
Evidence of antibodies to erythromycin in serum of a patient following an episode of acute drug-induced hepatitis. (8735873)
1996
41
Dystonia and drug-induced hepatitis in a patient treated with clozapine. (7694924)
1995
42
Role of reactive metabolites in drug-induced hepatitis. (8551007)
1995
43
Antituberculosis drug-induced hepatitis and HBsAg carriers. (8369519)
1993
44
Drug induced hepatitis. (1784106)
1991
45
Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. (3540968)
1987
46
Drug-induced hepatitis and lymphocyte transformation test in presence of prostaglandin inhibitor. (2871443)
1986
47
Antituberculosis drug-induced hepatitis--the dangers of rechallenge. (3764619)
1986
48
Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. (4029887)
1985
49
Drug induced hepatitis. (7156818)
1982
50
Recognition, prevention, and treatment of drug-induced hepatitis. (5766633)
1969

Variations for Drug-Induced Hepatitis

About this section

Expression for genes affiliated with Drug-Induced Hepatitis

About this section
Search GEO for disease gene expression data for Drug-Induced Hepatitis.

Pathways for genes affiliated with Drug-Induced Hepatitis

About this section

Pathways related to Drug-Induced Hepatitis according to GeneCards Suite gene sharing:

(show all 27)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
110.0UGT1A1, GSTT1
210.0CYP2E1, CYP2C19
310.0CYP2C9, UGT1A3
49.9GSTT1, GSTM1
59.9CYP2E1, CYP2C9
69.9CYP2C9, UGT1A1
7
Show member pathways
Codeine and morphine metabolism36
9.9CYP2D6, UGT1A1
8
Show member pathways
Glucocorticoid andamp; Mineralcorticoid Metabolism36
9.8UGT1A3, UGT1A1, CYP2E1
99.8CYP2E1, UGT1A1, UGT1A3
10
Show member pathways
acetate conversion to acetyl-CoA36
oxidative ethanol degradation III36
ethanol degradation IV36
9.8CYP2E1, CAT
11
Show member pathways
9.7UGT1A3, UGT1A1, GSTM1
12
Show member pathways
Catalytic cycle of mammalian FMOs36
9.7GSTM1, NAT1, NAT2
13
Show member pathways
9.6CYP2C19, CYP2C9, CYP2E1
14
Show member pathways
9.6UGT1A3, UGT1A1, NAT2, NAT1
15
Show member pathways
9.5CYP2C19, CYP2D6, CYP2C9
169.5UGT1A1, CYP2D6, CYP2E1, NAT2
17
Show member pathways
9.5CYP2C9, CYP2E1, NAT2, NAT1
189.4CYP2C9, CYP2E1, GSTM1, GSTT1
19
Show member pathways
9.3CYP2E1, CYP2C9, CYP2D6, CYP2C19
20
Show member pathways
9.3UGT1A1, CYP2C19, CYP2D6, CYP2C9
21
Show member pathways
Retinol metabolism58
9.1CYP2E1, CYP2C9, CYP2D6, CYP2C19, UGT1A3
22
Show member pathways
9.1UGT1A3, UGT1A1, CYP2C19, CYP2D6, CYP2C9
23
Show member pathways
thioredoxin pathway36
8.6ALB, CAT, TNF
24
Show member pathways
7.8UGT1A3, GSTT1, GSTM1, NAT1, NAT2, CYP2E1
25
Show member pathways
7.8CYP2E1, CYP2C9, CYP2D6, CYP2C19, UGT1A1, UGT1A3
26
Show member pathways
5.6GLUD1, GSTT1, GSTM1, ALB, CAT, NAT1

Compounds for genes affiliated with Drug-Induced Hepatitis

About this section

Compounds related to Drug-Induced Hepatitis according to GeneCards Suite gene sharing:

(show top 50)    (show all 595)
idCompoundScoreTop Affiliating Genes
1thiopurine439.5CYP2C19, CYP2D6, NAT2, CYP2C9
2flunitrazepam28 43 1211.5CYP2E1, UGT1A3, UGT1A1, CYP2C19, CYP2C9
3mephenytoin43 49 1211.4CYP2C19, CYP2E1, NAT2, CYP2D6, CYP2C9
4trichloroethylene439.4GSTM1, CYP2E1, GSTT1, GPT, NAT2
5cotinine43 2410.3GSTT1, UGT1A3, GSTM1, NAT2, CYP2D6, UGT1A1
6gsts439.3NAT2, GSTT1, CYP2D6, GSTM1, NAT1, CYP2E1
7arylamine439.2CYP2C19, NAT2, NAT1, GSTM1, GSTT1, CYP2D6
8debrisoquine43 4910.2CYP2E1, GSTM1, NAT2, CYP2C9, CYP2D6, CYP2C19
9tolbutamide43 28 49 1212.2GLUD1, CYP2E1, CYP2C19, NAT2, CYP2D6, CYP2C9
10paraxanthine43 2410.2NAT2, NAT1, CYP2C19, CYP2D6, CYP2C9, CYP2E1
11dapsone43 2 49 1212.2CYP2C9, CYP2D6, CYP2C19, NAT2, CYP2E1, NAT1
12Testosterone sulfate249.2CYP2E1, CYP2C9, CYP2D6, CYP2C19, UGT1A1, UGT1A3
13codeine43 28 49 24 1213.2UGT1A1, CYP2C19, CYP2D6, UGT1A3, CYP2C9, CYP2E1
14aflatoxin b143 2410.2SLC17A5, NAT1, NAT2, GSTT1, GSTM1
15chlorzoxazone43 28 1211.1CYP2D6, CYP2C9, SLC17A5, NAT2, CYP2C19, CYP2E1
16buprenorphine43 28 1211.1SLC17A5, CYP2C9, UGT1A3, CYP2D6, CYP2C19, UGT1A1
17imipramine43 28 49 24 1213.1CYP2C19, CYP2D6, UGT1A3, CYP2C9, CYP2E1, UGT1A1
18rifampin49 1210.1GSTT1, GSTM1, NAT2, UGT1A1, CYP2C19, CYP2C9
19uridine diphosphate439.1UGT1A3, NAT2, CYP2E1, CYP2C9, CYP2D6, UGT1A1
20sulfamethoxazole49 43 1210.9NAT1, GSTM1, ALB, NAT2, CYP2C9
21fluvastatin43 49 28 1211.9CYP2D6, GPT, CYP2C9, UGT1A3, UGT1A1, CYP2C19
22selegiline43 129.8CYP2C19, CYP2D6, CYP2C9, CYP2E1, CAT
23cyclophosphamide43 49 1210.7GSTT1, GSTM1, NAT2, CYP2E1, CYP2D6, CYP2C19
24phenobarbital43 28 49 1211.7CYP2E1, CYP2C9, CYP2C19, UGT1A1, GPT, GSTM1
25antipyrine43 129.7CYP2D6, ALB, CYP2C9, CYP2E1, CYP2C19, SLC17A5
26propofol43 49 1210.7UGT1A1, CYP2C19, CYP2D6, CYP2C9, CYP2E1, ALB
27diclofenac43 28 49 1211.6UGT1A3, UGT1A1, CYP2C19, CYP2D6, CYP2C9, CYP2E1
28estrone43 28 24 1211.6UGT1A3, UGT1A1, CYP2D6, CYP2C9, CYP2E1, ALB
29phenytoin43 49 28 1211.6SLC17A5, ALB, CYP2C9, UGT1A1, CYP2C19, CYP2D6
30rifampicin43 28 5910.5SLC17A5, NAT2, GPT, CYP2E1, CYP2C9, CYP2D6
31olanzapine43 49 28 24 1212.5SLC17A5, GLUD1, ALB, CYP2C9, CYP2D6, CYP2C19
32epoxide438.5GSTT1, GSTM1, NAT1, NAT2, CYP2E1, CYP2C9
33nicotine43 28 49 1211.5UGT1A3, UGT1A1, CYP2E1, GPT, CYP2C9, CYP2D6
34thalidomide43 49 59 1211.3CYP2E1, CYP2C19, CYP2C9, NAT2, TNF, GSTT1
35tamoxifen43 49 28 1211.2SLC17A5, GHR, CYP2E1, CYP2C9, CYP2D6, CYP2C19
36troglitazone43 28 59 1211.1UGT1A1, CYP2C19, UGT1A3, SLC17A5, CYP2C9, TNF
37pioglitazone28 43 49 1211.0CYP2D6, TNF, GPT, SLC17A5, CYP2C19, CYP2C9
38acetaminophen43 2 49 24 1212.0UGT1A1, CYP2C19, CYP2D6, CYP2C9, CYP2E1, GPT
39atorvastatin43 49 28 24 1211.9CYP2C19, CYP2D6, CYP2C9, GPT, TNF, SLC17A5
40valproic acid43 49 24 1210.9CYP2C19, CYP2D6, CYP2C9, CYP2E1, GPT, SLC17A5
41simvastatin43 49 59 28 24 1212.9GPT, UGT1A3, UGT1A1, CYP2C19, CYP2D6, SLC17A5
42vitamin a43 24 129.8GPT, GSTM1, NAT2, CYP2E1, CAT, SLC17A5
43estradiol43 24 129.6ALB, UGT1A3, UGT1A1, CYP2C19, CYP2E1, GHR
44rosiglitazone28 43 49 24 1211.6GPT, CYP2C9, CYP2C19, CYP2D6, TNF, ALB
45uric acid43 248.6GHR, SLC17A5, GPT, GLUD1, ALB, CAT
46isoniazid43 49 129.5CYP2C19, CYP2D6, CYP2C9, CYP2E1, GPT, NAT2
47creatinine437.3SLC17A5, CYP2E1, GPT, SORD, GLUD1, GSTT1
48testosterone43 59 24 129.9UGT1A3, GSTM1, ALB, GHR, CYP2E1, CYP2C9
49lactate436.9SLC17A5, GLUD1, GSTM1, ALB, CAT, SORD
50oxygen43 247.7CYP2D6, GHR, TNF, CYP2E1, GSTM1, GSTT1

GO Terms for genes affiliated with Drug-Induced Hepatitis

About this section

Cellular components related to Drug-Induced Hepatitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1endoplasmic reticulum membraneGO:00057898.8CYP2E1, CYP2C9, CYP2D6, CYP2C19, UGT1A1, UGT1A3

Biological processes related to Drug-Induced Hepatitis according to GeneCards Suite gene sharing:

(show all 17)
idNameGO IDScoreTop Affiliating Genes
1xenobiotic glucuronidationGO:005269710.2UGT1A3, UGT1A1
2flavonoid glucuronidationGO:005269610.2UGT1A3, UGT1A1
3retinoic acid metabolic processGO:004257310.0UGT1A1, UGT1A3
4drug catabolic processGO:004273710.0CYP2D6, CYP2C9
5omega-hydroxylase P450 pathwayGO:00972679.9CYP2C19, CYP2C9
6oxidative demethylationGO:00709899.8CYP2D6, CYP2C9
7exogenous drug catabolic processGO:00427389.8CYP2C9, CYP2C19
8heterocycle metabolic processGO:00464839.6UGT1A1, CYP2C19, CYP2D6, CYP2E1
9monoterpenoid metabolic processGO:00160989.6CYP2C19, CYP2D6, CYP2C9, CYP2E1
10epoxygenase P450 pathwayGO:00193739.6CYP2C9, CYP2C19
11drug metabolic processGO:00171449.3UGT1A1, CYP2C19, CYP2D6, CYP2C9, CYP2E1
12steroid metabolic processGO:00082029.3UGT1A1, CYP2C19, CYP2D6, CYP2C9, CYP2E1
13oxidation-reduction processGO:00551149.3CYP2C19, CYP2D6, CYP2C9, CYP2E1, GSTT1
14cellular amino acid biosynthetic processGO:00086529.2GLUD1, TNF, GPT
15response to drugGO:00424939.1GSTT1, TNF, CYP2E1, UGT1A1
16xenobiotic metabolic processGO:00068058.3GSTT1, UGT1A1, CYP2C19, CYP2D6, CYP2C9, CYP2E1
17small molecule metabolic processGO:00442816.6CYP2E1, CYP2C9, CYP2D6, CYP2C19, UGT1A1, GPT

Molecular functions related to Drug-Induced Hepatitis according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1arylamine N-acetyltransferase activityGO:000406010.1NAT2, NAT1
2(R)-limonene 6-monooxygenase activityGO:005274110.1CYP2C19, CYP2C9
3(S)-limonene 7-monooxygenase activityGO:001867610.1CYP2C19, CYP2C9
4(S)-limonene 6-monooxygenase activityGO:001867510.0CYP2C19, CYP2C9
5monooxygenase activityGO:00044979.6CYP2E1, CYP2C9, CYP2D6, CYP2C19
6steroid hydroxylase activityGO:00083959.6CYP2C9, CYP2C19
7oxidoreductase activityGO:00164919.5CYP2C19, CYP2D6, CYP2C9, CYP2E1
8oxygen bindingGO:00198259.4CYP2C19, CYP2E1, ALB
9antioxidant activityGO:00162099.4ALB, CAT
10iron ion bindingGO:00055069.4CYP2E1, CYP2C9, CYP2D6, CYP2C19
11drug bindingGO:00081449.2CYP2D6, CYP2C9, ALB
12heme bindingGO:00200379.1CYP2C19, CYP2D6, CYP2C9, CYP2E1, CAT
13protein homodimerization activityGO:00428038.7UGT1A3, UGT1A1, GHR, CAT, GSTM1
14enzyme bindingGO:00198998.4GSTM1, UGT1A3, UGT1A1, CYP2C19, CYP2E1, CAT

Products for genes affiliated with Drug-Induced Hepatitis

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Drug-Induced Hepatitis

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet